The CMS said the federal and state governments would save about $17.7 billion over five years with adjustments to the way Medicaid pays for prescription drugs.
A proposed rule, which implements provisions of the Patient Protection and Affordable Care Act
, seeks to make Medicaid reimbursement for medications more transparent and more closely aligned with what pharmacies pay for the drugs, according to a CMS news release
The regulations also would increase the rebates paid by drugmakers that participate in Medicaid and would establish rebates for drugs provided to enrollees in Medicaid managed-care plans, which are now exempt.
The proposed rule is scheduled to be published in the Federal Register on Feb. 2, and comments will be accepted until April 2.